Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities:
Net loss	$ (36,572,038)	$ (44,624,098)
Adjustments to reconcile net loss to net cash flows from operating activities:
Depreciation and amortization	783,127	936,231
Debt costs	481,858	101,975
Derivative loss (gain)	14,630,675	(499,671)
Purchase of Arcion license with common stock		2,072,136
Stock-based compensation expense	4,857,230	2,487,730
Changes in assets and liabilities:
Accounts receivable	2,588,811	(364,636)
Inventory	(2,023,786)
Prepaid expenses and other assets	(804,738)	(131,660)
Accounts payable and accrued liabilities	2,977,872	299,974
Income tax payable		85,000
Deferred revenue	2,282,208	(5,303,516)
Net cash flows from operating activities	(10,798,781)	(44,940,535)
Investing activities:
Purchase of equipment	(1,553,583)	(5,521)
Net cash flows from investing activities	(1,553,583)	(5,521)
Financing activities:
Proceeds from sale of common stock	70,717,786
Proceeds from exercise of stock options	4,572,919	347,434
Proceeds from notes payable and warrants	0	20,000,000
Deferred financing fees		(224,917)
Proceeds from exercise of common stock warrants	4,930,796
Payment of notes payable	(5,333,333)
Return of short swing profits	82,337
Change in amounts due to related parties		(69,706)
Net cash flows from financing activities	74,970,505	20,052,811
Net change in cash and cash equivalents	62,618,141	(24,893,245)
Cash and cash equivalents at beginning of period	23,175,809	63,189,307
Cash and cash equivalents at end of period	$ 85,793,950	$ 38,296,062